Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.66 - $2.41 $19,496 - $28,305
11,745 New
11,745 $27,000
Q2 2021

Aug 03, 2021

SELL
$13.68 - $22.34 $445,831 - $728,060
-32,590 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$9.0 - $63.91 $293,310 - $2.08 Million
32,590 New
32,590 $741,000
Q2 2019

Aug 09, 2019

SELL
$34.66 - $63.73 $133,371 - $245,233
-3,848 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$64.85 - $100.15 $11,608 - $17,926
179 Added 4.88%
3,848 $252,000
Q4 2018

Jan 29, 2019

BUY
$65.89 - $165.64 $130,462 - $327,967
1,980 Added 117.23%
3,669 $259,000
Q3 2018

Oct 26, 2018

BUY
$22.1 - $214.06 $37,326 - $361,547
1,689 New
1,689 $242,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $752M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.